Aspirin does little or nothing for hard arteries, researchers find

For decades, aspirin has been widely used to reduce the risk of cardiovascular problems. Now, a team led by a University of Florida Health researcher has found that aspirin may provide little or no benefit for certain patients who have plaque buildup in their arteries.

Aspirin is effective in treating strokes and heart attacks by reducing blood clots. The researchers tracked the health histories of over 33,000 patients with atherosclerosis -- narrowed, hardened arteries -- and determined that aspirin is marginally beneficial for those who have had a previous heart attack, stroke or other blood-flow issues involving arteries. However, among atherosclerosis patients with no prior heart attack or stroke, aspirin had no apparent benefit. The findings were published May 18 in the journal Clinical Cardiology.

Because the findings are observational, further study that includes clinical trials are needed before definitively declaring that aspirin has little or no effect on certain atherosclerosis patients, said Anthony Bavry, M.D., an associate professor in the UF College of Medicine's department of medicine and a cardiologist at the Malcom Randall Veterans Affairs Medical Center in Gainesville.

"Aspirin therapy is widely used and embraced by cardiologists and general practitioners around the world. This takes a bit of the luster off the use of aspirin," Bavry said.

Bavry said the findings do not undercut aspirin's vital role in more immediate situations: If a heart attack or stroke is underway or suspected, patients should still take aspirin as a treatment measure.

"The benefit of aspirin is still maintained in acute events like a heart attack or a stroke," he said.

Among more than 21,000 patients who had a previous heart attack or stroke, researchers found that the risk of subsequent cardiovascular death, heart attack or stroke was marginally lower among aspirin users.

For those atherosclerosis patients who had not experienced a heart attack or stroke, aspirin appeared to have no effect. The risk of cardiovascular death, heart attack and stroke was 10.7 percent among aspirin users and 10.5 percent for non-users.

Patients who enrolled in the nationwide study were at least 45 years old with coronary artery disease, cerebrovascular disease or peripheral vascular disease. Their medical data were collected between late 2003 and mid-2009.

The researchers did identify one group that got some benefit from aspirin -- people who had a coronary bypass or stent but no history of stroke, heart attack or arterial blood-flow condition. Those patients should clearly stay on an aspirin regimen, Bavry said. Bavry said discerning aspirin's effectiveness for various patients is also important because the medicine can create complications, including gastrointestinal bleeding and, less frequently, bleeding in the brain. Because of insufficient data, the current study wasn't able to address the extent of aspirin's role in bleeding cases.

"The cardiology community needs to appreciate that aspirin deserves ongoing study. There are many individuals who may not be deriving a benefit from aspirin. If we can identify those patients and spare them from aspirin, we're doing a good thing," he said.

The current findings are the second time this year that Bavry and his collaborators have published research about the apparent ineffectiveness of aspirin therapy. In April, the group showed that the drug may not provide cardiovascular benefits for people with peripheral vascular disease, which causes narrowed arteries and reduced blood flow to the limbs.

Bavry also cautioned patients with atherosclerosis or peripheral vascular disease not to quit aspirin therapy on their own. Instead, they should discuss the matter with their physician, he said.

Story Source:
ScienceDaily

Journal Reference:
Anthony A. Bavry, Islam Y. Elgendy, Yedid Elbez, Ahmed N. Mahmoud, Emmanuel Sorbets, Philippe Gabriel Steg, Deepak L. Bhatt. Aspirin and the risk of cardiovascular events in atherosclerosis patients with and without prior ischemic events. Clinical Cardiology, 2017; DOI: 10.1002/clc.22724


Comments

Post a Comment

Popular posts from this blog

NEEM TREE & MEDICINAL USES

Image
NEEM TREE & MEDICINAL USES "Dogo Yarow" The TREE of LIFE The Magical Evergreen Tree The neem plant is native to India but gradually spread to many parts of the world over the years. IT HAS BEEN USED LOCALLY AS MEDICINE OVER THOUSANDS OF YEARS, AND OVER THE CENTURIES IN PHARMACEUTICALS, COSMETICS AND TOILETRIES. Almost every part of this wonder plant is Medicinal, ranging from roots, bark, twigs, leaves, flowers and seeds...... It's very common within the Hausa communities in Cameroon more especially in the Northen regions which predominantly occupied by the Hausa ethnic group. They call it Dogo Yarow which when translated means, TALL CHILD or TALL PIKIN in Pidgin English..... MEDICINAL USES OF THE TREE OF LIFE - NEEM: * Cardiac Problems: Infusions of leaves in HOT water when taken removes bad sugars and toxins from blood, dilates blood vessels, improves blood circulation and balances heart pumping rates * High Blood Pressure: It relaxes erratic heart beats a
Read more

TAPE WORMS: Unwanted 'Guests' in the Intestines

Image
https://m.facebook.com/story.php?story_fbid=261432537653223&id=193799827749828 Tapeworms are flat, segmented worms that live in the intestines of some animals. Animals can become infected with these parasites when grazing in pastures or drinking contaminated water. Eating undercooked meat from infected animals is the main cause of tapeworm infection in people. Although tapeworms in humans usually cause few symptoms and are easily treated, they can sometimes cause serious, life-threatening problems. That's why it's important to recognize the symptoms and know how to protect yourself and your family. Tapeworm Causes Six types of tapeworms are known to infect people. They are usually identified by the animals they come from -- for example, Taenia saginata from beef, Taenia solium from pork, and Diphyllobothrium latum from fish. Tapeworms have a three-stage lifecycle: egg, an immature stage called a larva, and an adult stage at which the worm can produce more eggs. Bec
Read more

8,260 students graduate as ABU holds 40th convocation tomorrow

Image
The 40th convocation ceremony of the Ahmadu Bello University (ABU), Zaria will hold tomorrow with 8,260 students graduating with first degrees. The Vice Chancellor of the university, Professor Ibrahim Garba, made this known during a press briefing yesterday, saying that the convocation would confirm the graduation of 256 PhD students. He said the number of PhD and about 3,600 other postgraduate graduands was a confirmation of the new status that ABU had assumed where priority was given to postgraduate studies. Professor Garba said ABU was expanding its carrying capacity through introduction of new programmes to accommodate more applicants who usually overwhelmed the school. “It is in this direction that we now allow more institutions to run degree programmes with our affiliation.  We have also introduced distance learning where we admit hundreds of students and we would commence undergraduate studies in the centre,” he said.
Read more